Qingdao Baheal Medical INC. Statistics

Total Valuation

Qingdao Baheal Medical INC. has a market cap or net worth of CNY 15.27 billion. The enterprise value is 16.24 billion.

Market Cap	15.27B
Enterprise Value	16.24B

Important Dates

The last earnings date was Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	May 29, 2024

Share Statistics

Qingdao Baheal Medical INC. has 525.61 million shares outstanding. The number of shares has increased by 1.11% in one year.

Current Share Class	n/a
Shares Outstanding	525.61M
Shares Change (YoY)	+1.11%
Shares Change (QoQ)	-0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	12.64%
Float	104.22M

Valuation Ratios

The trailing PE ratio is 21.76 and the forward PE ratio is 17.93.

PE Ratio	21.76
Forward PE	17.93
PS Ratio	1.90
PB Ratio	6.00
P/TBV Ratio	n/a
P/FCF Ratio	31.78
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.74, with an EV/FCF ratio of 33.79.

EV / Earnings	24.74
EV / Sales	2.04
EV / EBITDA	15.74
EV / EBIT	16.64
EV / FCF	33.79

Financial Position

The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.49.

Current Ratio	2.45
Quick Ratio	1.97
Debt / Equity	0.49
Debt / EBITDA	1.33
Debt / FCF	2.68
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 26.00% and return on invested capital (ROIC) is 15.53%.

Return on Equity (ROE)	26.00%
Return on Assets (ROA)	11.35%
Return on Capital (ROIC)	15.53%
Revenue Per Employee	2.86M
Profits Per Employee	248,412
Employee Count	2,642
Asset Turnover	1.46
Inventory Turnover	7.94

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.41% in the last 52 weeks. The beta is 0.55, so Qingdao Baheal Medical INC.'s price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-10.41%
50-Day Moving Average	25.98
200-Day Moving Average	28.34
Relative Strength Index (RSI)	51.93
Average Volume (20 Days)	4,686,339

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Qingdao Baheal Medical INC. had revenue of CNY 7.56 billion and earned 656.31 million in profits. Earnings per share was 1.23.

Revenue	7.56B
Gross Profit	2.27B
Operating Income	938.23M
Pretax Income	873.58M
Net Income	656.31M
EBITDA	968.17M
EBIT	938.23M
Earnings Per Share (EPS)	1.23

Full Income Statement

Balance Sheet

The company has 1.21 billion in cash and 1.29 billion in debt, giving a net cash position of -82.15 million or -0.16 per share.

Cash & Cash Equivalents	1.21B
Total Debt	1.29B
Net Cash	-82.15M
Net Cash Per Share	-0.16
Equity (Book Value)	2.64B
Book Value Per Share	5.08
Working Capital	2.63B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 609.70 million and capital expenditures -129.24 million, giving a free cash flow of 480.47 million.

Operating Cash Flow	609.70M
Capital Expenditures	-129.24M
Free Cash Flow	480.47M
FCF Per Share	0.91

Full Cash Flow Statement

Margins

Gross margin is 29.98%, with operating and profit margins of 12.40% and 8.68%.

Gross Margin	29.98%
Operating Margin	12.40%
Pretax Margin	11.55%
Profit Margin	8.68%
EBITDA Margin	12.80%
EBIT Margin	12.40%
FCF Margin	6.35%

Dividends & Yields

This stock pays an annual dividend of 0.76, which amounts to a dividend yield of 2.49%.

Dividend Per Share	0.76
Dividend Yield	2.49%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	65.80%
Buyback Yield	-1.11%
Shareholder Yield	1.38%
Earnings Yield	4.23%
FCF Yield	3.15%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a